Get started

Financials · TNON

Tenon Medical Inc. (TNON) financials

For the twelve months ended Jun 30, 2026, Tenon Medical Inc. reported $5.31M of revenue and -$13.70M of net income.

Revenue, TTM
$5.31M
Revenue growth, YoY
+80.3%
Net income, TTM
-$13.70M
Net margin
-257.9%
Free cash flow, TTM
-$12.30M
Cash
$1.68M
P/S
0.83
Market cap
$4.4M
Annual revenue$3.94M
FY2021FY2025
Annual net income-$12.56M
FY2021FY2025
Annual free cash flow-$11.02M
FY2021FY2025

TNON revenue and earnings growth

TNON revenueQ2 2026$1.28M

Quarter YoY
+126.8%
QoQ
-7.3%
FY YoY
+20.4%

TNON revenue was $1.28M in fiscal Q2 2026 (ended Jun 30, 2026), up 126.8% from a year earlier and down 7.3% from the prior quarter. For the full fiscal 2025 it was $3.94M, up 20.4% from fiscal 2024. It rose in each of the last 4 fiscal years. Fiscal 2025 is the highest of the 5 fiscal years on file.

TNON net incomeQ2 2026-$4.05M

TNON net income was -$4.05M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$2.77M a year earlier. For the full fiscal 2025 it was -$12.56M, compared with -$13.67M in fiscal 2024.

TNON EPSQ2 2026-$12.35

TNON diluted EPS was -$12.35 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$59.50.

TNON free cash flowQ2 2026-$2.93M

TNON free cash flow was -$2.93M in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$11.02M, compared with -$10.06M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
Revenue$3.94M$3.28M$2.93M$691.0K$160.0K
Cost of revenue$1.59M$1.57M$1.69M$1.33M$55.0K
Gross profit$2.36M$1.71M$1.24M-$641.0K$105.0K
Research and development$2.15M$2.60M$3.16M$2.83M$1.72M
Selling, general and admin$6.97M$7.76M$7.03M$7.42M$2.71M
Operating income-$12.79M-$13.77M-$15.73M-$18.73M-$6.46M
Interest expense-$34.0K$21.0K$354.0K-
Pre-tax income----$18.92M-$7.08M
Net income-$12.56M-$13.67M-$15.58M-$18.92M-$7.05M
EPS, basic-$59.50-$394.10-$2402.40-$6613.60-$21868.00
EPS, diluted-$59.50-$394.10-$2402.40-$6613.60-$21868.00
Diluted shares210.97134.6866.4862.8610.323

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
Cash and equivalents$3.76M$6.54M$2.43M$2.13M$2.92M
Short-term investments---$6.44M$4.40M
Receivables$1.70M$863.0K$518.0K$228.0K$76.0K
Inventory$1.05M$606.0K$554.0K$415.0K$188.0K
Current assets$6.77M$8.21M$3.89M$9.35M$7.67M
Goodwill$2.41M----
Total assets$10.76M$9.84M$6.34M$11.09M$9.27M
Current liabilities$3.21M$1.87M$3.14M$2.53M$15.27M
Total liabilities$5.72M$3.87M$5.57M$4.84M$16.18M
Shareholders' equity$5.04M$5.97M$778.0K$6.25M-$20.55M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
Operating cash flow-$10.74M-$9.88M-$12.18M-$12.03M-$4.29M
Capital expenditures$273.0K$186.0K$361.0K$847.0K$102.0K
Free cash flow-$11.02M-$10.06M-$12.54M-$12.87M-$4.39M
Investing cash flow-$1.02M-$186.0K$6.14M-$2.88M-$4.50M
Financing cash flow$8.99M$14.13M$6.30M$14.11M$11.47M
Stock-based compensation$1.69M$3.85M$4.14M$2.90M$377.0K
Depreciation and amortization$262.0K$408.0K$199.0K$78.0K-

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
Revenue growth, YoY20.4%11.9%323.7%331.9%-
Gross margin59.8%52.2%42.4%-92.8%65.6%
Operating margin-324.3%-420.1%-537.1%-2709.8%-4038.1%
Net margin-318.4%-417.2%-532.1%-2737.6%-4405.0%
Free cash flow margin-279.4%-307.1%-428.4%-1862.8%-2746.3%
Return on equity-249.1%-229.0%-2002.7%-302.6%-
Return on assets-116.7%-138.9%-245.6%-170.6%-76.0%
Current ratio2.114.391.243.690.50

Source: XBRL data Tenon Medical Inc. files with the SEC, latest filing dated Aug 13, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 1-for-10, first reported Nov 14, 2023; 1-for-8, first reported Nov 14, 2024; 1-for-35, first reported Aug 13, 2026.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

TNON peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
TNON$5.31M+80.3%-$13.70M-257.9%$4.4M
SYK$26.30B+7.9%$3.62B13.8%$124.05B
MMM$25.25B+1.7%$3.54B14.0%$95.67B
BSX$21.07B+8.9%$3.50B16.6%$61.96B
BDX$23.25B+17.4%$941.00M4.0%$57.71B
MDLN$30.68B-$683.00M2.2%$52.13B
RMD$5.73B+9.0%$1.59B27.8%$33.10B
DXCM$5.10B+13.0%$991.00M19.4%$29.62B
WST$3.40B+12.6%$638.90M18.8%$27.85B

TNON FAQ

8 questions
  • What is TNON revenue?
    Tenon Medical Inc. (TNON) reported $5.31M of revenue for the twelve months ended Jun 30, 2026. That is up 80.3% from the year before. Revenue for fiscal 2025 was $3.94M.
  • Is TNON profitable?
    No. Tenon Medical Inc. reported a net loss of $13.70M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does TNON have?
    Tenon Medical Inc. reported $1.68M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is TNON revenue growing?
    Tenon Medical Inc.'s revenue changed +20.4% in fiscal 2025, to $3.94M.
  • What is TNON gross margin?
    Tenon Medical Inc.'s gross profit was $3.55M on $5.31M of revenue for the twelve months ended Jun 30, 2026, a gross margin of 66.8%.
  • What is TNON free cash flow?
    Tenon Medical Inc. generated -$12.30M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$11.77M less capital expenditures.
  • When did TNON last report financial results?
    The latest statements here come from Tenon Medical Inc.'s 10-Q filed on Aug 13, 2026, covering the period ended Jun 30, 2026.
  • Where does this TNON financial data come from?
    Quantisnow builds these statements from the structured XBRL data Tenon Medical Inc. files with the SEC. It is provided for information only and is not investment advice.